IRIS
MISSO, Gabriella
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 5.945
NA - Nord America 3.595
AS - Asia 2.535
SA - Sud America 340
Continente sconosciuto - Info sul continente non disponibili 263
AF - Africa 35
OC - Oceania 5
Totale 12.718
Salva come PNG Salva come JPEG
Nazione #
RU - Federazione Russa 3.957
US - Stati Uniti d'America 3.543
SG - Singapore 815
IE - Irlanda 556
CN - Cina 543
IT - Italia 457
VN - Vietnam 397
BR - Brasile 293
HK - Hong Kong 281
DE - Germania 220
GB - Regno Unito 214
UA - Ucraina 189
KR - Corea 148
JP - Giappone 108
FI - Finlandia 78
FR - Francia 65
IN - India 64
TR - Turchia 57
GR - Grecia 56
SE - Svezia 31
PK - Pakistan 29
CA - Canada 19
AT - Austria 18
PL - Polonia 16
BE - Belgio 15
MX - Messico 15
BD - Bangladesh 14
ES - Italia 14
CO - Colombia 12
IR - Iran 12
NL - Olanda 12
ZA - Sudafrica 12
AR - Argentina 11
CZ - Repubblica Ceca 11
ID - Indonesia 11
IQ - Iraq 11
EC - Ecuador 9
LT - Lituania 7
UZ - Uzbekistan 7
CR - Costa Rica 6
MA - Marocco 6
BG - Bulgaria 5
CH - Svizzera 5
AE - Emirati Arabi Uniti 4
AU - Australia 4
CL - Cile 4
IL - Israele 4
PY - Paraguay 4
SA - Arabia Saudita 4
TN - Tunisia 4
TW - Taiwan 4
JM - Giamaica 3
KE - Kenya 3
PH - Filippine 3
RS - Serbia 3
SC - Seychelles 3
TH - Thailandia 3
VE - Venezuela 3
AL - Albania 2
BO - Bolivia 2
BY - Bielorussia 2
DK - Danimarca 2
DZ - Algeria 2
EG - Egitto 2
HN - Honduras 2
HU - Ungheria 2
KZ - Kazakistan 2
MD - Moldavia 2
NP - Nepal 2
RO - Romania 2
AM - Armenia 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
BS - Bahamas 1
DM - Dominica 1
DO - Repubblica Dominicana 1
EU - Europa 1
GE - Georgia 1
GH - Ghana 1
GT - Guatemala 1
JO - Giordania 1
KG - Kirghizistan 1
KH - Cambogia 1
MG - Madagascar 1
MY - Malesia 1
NI - Nicaragua 1
NO - Norvegia 1
OM - Oman 1
PE - Perù 1
PR - Porto Rico 1
PS - Palestinian Territory 1
PT - Portogallo 1
QA - Qatar 1
SI - Slovenia 1
SN - Senegal 1
TJ - Tagikistan 1
TT - Trinidad e Tobago 1
TV - Tuvalu 1
UY - Uruguay 1
Totale 12.456
Salva come PNG Salva come JPEG
Città #
Moscow 1.475
Dallas 573
Dublin 556
San Jose 403
Singapore 399
Santa Clara 336
Chandler 308
Jacksonville 300
Hong Kong 277
Ashburn 209
Seoul 145
Ho Chi Minh City 108
Beijing 94
New York 92
Hefei 82
Ann Arbor 81
Hanoi 78
Dong Ket 72
Princeton 69
Naples 68
Bremen 61
Medford 61
Roxbury 53
Boardman 51
Caserta 42
Council Bluffs 42
Los Angeles 41
Bengaluru 40
Aversa 38
Woodbridge 36
Munich 30
Wilmington 29
Des Moines 27
São Paulo 27
The Dalles 23
Da Nang 22
Helsinki 20
San Mateo 20
Napoli 19
Nuremberg 19
Milan 16
Orem 16
Warsaw 16
Brussels 15
Mountain View 15
Falkenstein 14
Istanbul 12
Brno 11
Cambridge 11
Haiphong 11
San Francisco 11
London 10
Memphis 10
Rome 10
San Nicola la Strada 10
Tokyo 10
Brooklyn 9
Johannesburg 9
Phoenix 9
Piscataway 9
Rio de Janeiro 9
Tianjin 9
Vienna 9
Zhengzhou 9
Bahawalpur 8
Brasília 8
Chennai 8
Falls Church 8
Frankfurt am Main 8
Mexico City 8
Boston 7
Cava Dei Tirreni 7
Denver 7
Düsseldorf 7
Houston 7
Lappeenranta 7
Montreal 7
Shanghai 7
Belo Horizonte 6
Biên Hòa 6
Chicago 6
Curitiba 6
Guangzhou 6
Madrid 6
Nanjing 6
Viterbo 6
Afragola 5
Amsterdam 5
Auburn Hills 5
Avellino 5
Buffalo 5
Jakarta 5
Manchester 5
Paris 5
Phủ Lý 5
Phủ Từ Sơn 5
Shenzhen 5
Changsha 4
Ercolano 4
Fortaleza 4
Totale 6.915
Salva come PNG Salva come JPEG
Nome #
Comparative study of NGS platform ion torrent personal genome machine and therascreen rotor-gene Q for the detection of somatic variants in cancer. 253
Mitochondria as playmakers of apoptosis, autophagy and senescence 200
A miRNA signature suggestive of nodal metastases from laryngeal carcinoma. 197
"Phase II trial of bevacizumab and dose/dense chemoterapy with cisplatin and metronomic daily oral etoposide in advanced non small cell lung cancer patients" 193
Antagonistic effects of chloroquine on autophagy occurrence potentiate the anticancer effects of everolimus on renal cancer cells 193
Long-term neuropathic pain behaviors correlate with synaptic plasticity and limbic circuit alteration: a comparative observational study in mice 187
A hydroquinone-based derivative elicits apoptosis and autophagy via activating a ros-dependent unfolded protein response in human glioblastoma 185
Prognostic value of EGFR and EGFR-MEDIATED transduction signal inhibition: effective therapeutic strategies in the management of laryngeal cancer 184
Anti-cancer activity of dose-fractioned mPE +/- bevacizumab regimen is paralleled by immune-modulation in advanced squamous NSLC patients 184
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition) 180
Poorly differentiated neuroendocrine larynx carcinoma: Clinical features and mirnas signature—a new goal for early diagnosis and therapy? 171
miR-125b Upregulates miR-34a and Sequentially Activates Stress Adaption and Cell Death Mechanisms in Multiple Myeloma 170
MiR-449a antagonizes EMT through IL-6-mediated trans-signaling in laryngeal squamous cancer 169
W7FW14F apomyoglobin amyloid aggregates-mediated apoptosis is due to oxidative stress and AKT inactivation caused by Ras and Rac 167
MicroRNAs’ Crucial Role in Salivary Gland Cancers’ Onset and Prognosis 167
Fluorescent nanodiamonds as innovative delivery systems for MiR-34a replacement in breast cancer 165
Definition of miRNA Signatures of Nodal Metastasis in LCa: miR-449a Targets Notch Genes and Suppresses Cell Migration and Invasion 165
Combined use of free light chain and heavy/light chain ratios allow diagnosis and monitoring of patients with monoclonal gammopathies: Experience of a single institute, with three exemplar case reports 163
Definition of microRNAs predictive of nodal involvement in laringeal cancer patients 163
Cytotoxic drugs up-regulate Epidermal Growth Factor Receptor (EGFR) expression in colon cancer cells and enhance their susceptibility to EGFR-targeted Antibody-Dependent-Cell-mediated-Cytotoxicity (ADCC) 162
Gene interference strategies as a new tool for the treatment of prostate cancer 162
Immune cell infiltration and inflammatory landscape in primary brain tumours 160
Antiproliferative effects of ruthenium-based nucleolipidic nanoaggregates in human models of breast cancer in vitro: insights into their mode of action 159
Lanreotide Induces Cytokine Modulation in Intestinal Neuroendocrine Tumors and Overcomes Resistance to Everolimus 157
Overview on Molecular Biomarkers for Laryngeal Cancer: Looking for New Answers to an Old Problem 157
Exosomes multiplex profiling, a promising strategy for early diagnosis of laryngeal cancer 155
Core-shell biodegradable nanoassemblies for the passive targeting of docetaxel: features, antiproliferative activity and in vivo toxicity. 154
Biosensore per rivelazione di firma molecolare di miRNA ad interesse diagnostico in patologie umane 152
Gastrointestinal Hormones, Intestinal Microbiota and Metabolic Homeostasis in Obese Patients: Effect of Bariatric Surgery 152
Advancing prognostic understanding in hepatocellular carcinoma through the integration of genomic instability and lncRNA signatures: GILncSig model 151
Bisphosphonates and cancer: what opportunities from nanotechnology? 150
Advancing prognostic understanding in hepatocellular carcinoma through the integration of genomic instability and lncRNA signatures: GILncSig model 149
null 147
Molecular markers as a new tool for diagnostic and prognostic definition of type 2 diabetes mellitus 146
Identification and bioinformatic characterization of a serum miRNA signature for early detection of laryngeal squamous cell carcinoma 144
Identification of Tissue miRNA Signatures for Pancreatic Ductal Adenocarcinoma 143
Impact of anemia management with EPO on psychologic distress in cancer patients: results of a multicenter patient survey. 143
Evaluation of the in vitro and in vivo antiangiogenic effects of denosumab and zoledronic acid. 141
Immune-modulating effects of bevacizumab in metastatic non-small-cell lung cancer patients 140
Radiotherapy prolongs the survival of advanced non-smallcell lung cancer patients undergone to an immune-modulating treatment with dose-fractioned cisplatin and metronomic etoposide and bevacizumab (mPEBev) 140
Flexible 3D nanofiber-based SERS biosensor for detection of miRNA-223-3p in early Laryngeal Cancer diagnosis 138
Emerging strategies to strengthen the anti-tumour activity of type I IFNs: overcoming survival pathways 138
Nanoparticelle e loro usi 134
Emerging pathways as individualized therapeutic target of multiple myeloma. 134
Possible roles of transglutaminases in molecular mechanisms responsible for cancer and human neurodegenerative diseases. 133
Breast Cancer Chemotherapeutic Options: A General Overview on the Preclinical Validation of a Multi-Target Ruthenium(III) Complex Lodged in Nucleolipid Nanosystems 133
Tumour-specific uptake of anti-cancer drugs: the future is here. 132
Possible antioxidant role of SPA therapy with chlorine-sulphur-bicarbonate mineral water. 132
Evidence of novel miR-34a-based therapeutic approaches for multiple myeloma treatment 130
Transferrin-Conjugated SNALPs Encapsulating 2'-O-Methylated miR-34a for the Treatment of Multiple Myeloma 128
Tumor infiltrating T lymphocytes expressing FoxP3, CCR7 or PD-1 predict the outcome of prostate cancer patients subjected to salvage radiotherapy after biochemical relapse 127
Tissue expression of miR-449a as risk factor for occult neck metastasis in patients with cT3-T4 N0 laryngeal cancer. A pilot study 126
Urotensin-II receptor: a double identity receptor involved in vasoconstriction and in the development of digestive tract cancers and other tumors 126
High throughput screening for inhibitors of the HECT ubiquitin E3 ligase ITCH identifies antidepressant drugs as regulators of autophagy. 125
Nanocarriers Conjugated with Cell Penetrating Peptides: New Trojan Horses by Modern Ulysses 123
Insight toward the microRNA profiling of laryngeal cancers: Biological role and clinical impact 123
Optimal Management of Prostate Cancer Based on its Natural Clinical History 122
Clinical and Molecular Characteristics of Rare Malignant Tumors of Colon and Rectum 122
MOLECULAR TARGETS FOR THE TREATMENT OF MULTIPLE MYELOMA 121
Measurement of autophagy by flow cytometry 121
Immune-modulating Effects of the Newest Cetuximab-based Chemoimmunotherapy Regimen in Advanced Colorectal Cancer Patients. 120
Pharmacological inhibition of HSP90 and ras activity as a new strategy in the treatment of HNSCC. 120
Long non-coding RNAs as important biomarkers in laryngeal cancer and other head and neck tumours 120
Synergistic inhibition of human colon cancer cell growth by the cannabinoid CB1 receptor antagonist rimonabant and oxaliplatin 119
Myrtucommulone production by a strain of Neofusicoccum australe endophytic in myrtle (Myrtus communis). 119
Non Coding RNAs: A New Avenue for the Self-Tailoring of Blood Cancer Treatment 119
Bioactivity and Development of Small Non-Platinum Metal-Based Chemotherapeutics 116
miR-29b sensitizes multiple myeloma cells to bortezomib-induced apoptosis through the activation of a feedback loop with the transcription factor Sp1. 116
Mir-34: a new weapon against cancer? 116
Early detection of laryngeal cancer: prominence of miRNA signature as a new tool for clinicians 116
In vivo activity of miR-34a mimics delivered by stable nucleic acid lipid particles (SNALPs) against multiple myeloma. 114
Gemcitabine, oxaliplatin, levofolinate, 5-fluorouracil, granulocyte-macrophage colony-stimulating factor, and interleukin-2 (GOLFIG) versus FOLFOX chemotherapy in metastatic colorectal cancer patients: The GOLFIG-2 multicentric open-label randomized phase III trial 114
Lipid Nanoparticles to Deliver miRNA in Cancer 112
Synergistic activity of everolimus and 5-aza-2'-deoxycytidine in medullary thyroid carcinoma cell lines 112
Zoledronic acid affects the cytotoxic effects of Chlamydia pneumoniae and the modulation of cytokine production in human osteosarcoma cells. 111
Exploring cellular uptake, accumulation and mechanism of action of a cationic Ru-based nanosystem in human preclinical models of breast cancer 111
Role of perineural invasion as a prognostic factor in laryngeal cancer 110
The route to solve the interplay between inflammation, angiogenesis and anti-cancer immune response 110
Hepatocarcinoma: genetic and epigenetic features 107
MICRO-RNAs as biological markers for prevention and diagnosis of oral carcinomas 101
Tumour Burden Reporting in Phase III Clinical Trials of Metastatic Lung, Breast, and Colorectal Cancers: A Systematic Review 100
Therapeutic targeting of miR-29b/HDAC4 epigenetic loop in multiple myeloma 100
Non-coding RNAs as a new dawn in tumor diagnosis 98
Interleukin-2 and lanreotide in the treatment of medullary thyroid cancer: in vitro and in vivo studies. 96
Strain Analysis in the Assessment of a Mouse Model of Cardiotoxicity due to Chemotherapy: Sample for Preclinical Research 95
Genetic landscape of colorectal cancer patients manifesting tumor shrinkage during SARS-Cov-2 infection 94
Safety and efficacy evaluation in vivo of a cationic nucleolipid nanosystem for the nanodelivery of a ruthenium(Iii) complex with superior anticancer bioactivity 94
Proteomic profiling identifies miR-423-5p as a modulator of oncogenic metabolism in HCC 92
Aminobisphosphonates and nano technologically-modified aminobisphosphonates: A new dawn in the treatment of bone and extra-bone tumors? 91
Triple Negative Breast Cancer Preclinical Therapeutic Management by a Cationic Ruthenium-Based Nucleolipid Nanosystem 90
Prognostic patterns for predicting lymph node metastasis in patients with squamous cell carcinoma of the larynx 89
Complex genetic landscape in CLL: Clinical impact on patients’ survival and insights into the altered molecular pathways 85
MiR-423-5p is a metabolic and growth tuner in hepatocellular carcinoma via MALAT-1 and mitochondrial interaction 80
miRNA–lncRNA Cross-Regulation Landscape in Cancer: From Molecular Mechanisms to Therapeutic and Diagnostic Applications 21
Electrochemical liquid biopsy across cancer care pathway 10
p63 and ZNF148 cooperate to regulate head and neck squamous cell carcinoma 6
Ferroptosis Among the Antiproliferative Pathways Activated by a Lipophilic Ruthenium(III) Complex as a Candidate Drug for Triple-Negative Breast Cancer 4
microRNA Detection via Nanostructured Biochips for Early Cancer Diagnostics 2
Totale 12.718
Salva come PNG Salva come JPEG
Categoria #
all - tutte 41.282
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 41.282
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022421 0 12 1 7 147 11 6 14 18 25 43 137
2022/20231.138 125 19 18 118 104 121 4 63 506 19 23 18
2023/2024645 35 15 90 29 148 82 7 23 37 9 46 124
2024/20251.464 27 31 6 85 232 195 209 119 226 117 123 94
2025/20267.342 280 388 859 281 568 3.671 384 334 188 236 100 53
2026/2027173 47 126 0 0 0 0 0 0 0 0 0 0
Totale 12.718